BERWYN, PA — Virpax Pharmaceuticals, Inc. (Nasdaq: VRPX) has announced the successful completion of a full study on its ...

Virpax completed a U.S. Army-backed Probudur study, showing potential for prolonged pain relief and reduced opioid use in surgical recovery.

BERWYN, Pa. - Virpax Pharmaceuticals, Inc. (NASDAQ:VRPX), a micro-cap pharmaceutical company with a market capitalization of $1.43 million focused on non-addictive pain management treatments, has ...

Virpax Pharmaceuticals, Inc. ("Virpax" or the "Company"), a company specializing in developing non-addictive products for pain management, post-traumatic stress disorder, central nervous system (CNS) ...

Virpax Pharmaceuticals (VRPX) announced the completion of the full study that followed the initial Probudur pilot study performed by the U.S.

Retired software company boss Markus Rasche (pictured), 64, a father-of-one from North Yorkshire, was one of the first to ...

As an orthopedic and sports medicine surgeon and chairman at Inova Sports Medicine, Dr. Robin West is no stranger to sports-related injuries. She understands that developing an effective game plan to ...

While New Orleans prepares for the excitement of the big game, it’s important to remember that sports injuries aren’t limited to the professionals. High school athletes, weekend warriors, and generall ...

Detailed price information for Pacira Pharm Inc (PCRX-Q) from The Globe and Mail including charting and trades.

Detailed price information for Pacira Pharm Inc (PCRX-Q) from The Globe and Mail including charting and trades.